Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros

Base de dados
Tipo de documento
País/Região como assunto
Intervalo de ano de publicação
1.
J Mol Biol ; 274(1): 16-20, 1997 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-9398511

RESUMO

The crystal structure of recombinant human annexin V complexed with K-201, an inhibitor of the calcium ion channel activity of annexin V, was solved at 3.0 A by molecular replacement including the apo and high-calcium forms. K-201 was bound at the hinge region cavity formed by the N-terminal strand and domains II, III and IV, at the side opposite the calcium and membrane-binding surface, in an L-shaped conformation. Based on the complex and other annexin structures, K-201 is proposed to restrain the hinge movement of annexin V in an allosteric manner, resulting in the inhibition of calcium movement across the annexin V molecule.


Assuntos
Anexina A5/química , Bloqueadores dos Canais de Cálcio/química , Canais de Cálcio/efeitos dos fármacos , Tiazepinas/química , Anexina A5/genética , Anexina A5/metabolismo , Cristalografia por Raios X , Humanos , Ligantes , Modelos Moleculares , Ligação Proteica , Proteínas Recombinantes/química , Espectrometria de Fluorescência , Tiazepinas/metabolismo
2.
J Int Med Res ; 33(3): 295-300, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15938590

RESUMO

We developed a system to measure nitric oxide (NO) concentration during cardiopulmonary bypass in anaesthetized pigs (n = 6). A T-shaped connector, attached to an NO sensor, was mounted in the extracorporeal circuit at two measuring sites: proximal to the membrane oxygenator (venous side) and distal to the arterial line filter (arterial side). After performing a preliminary validation study, we measured plasma NO concentration before and during total cardiopulmonary bypass circulation (non-pulsatile flow 1.5 l/min) and without pulmonary ventilation. After establishing bypass, PaO2 was 318 - 393 mmHg; when PaO2 was decreased to 80 - 100 mmHg, plasma NO concentration in the arterial circuit fell by 39.2 +/- 15.6 nM. There was no observable change in plasma NO concentration at the venous circuit. This new system could be useful in monitoring NO concentration during cardiac surgery with cardiopulmonary bypass, and for understanding the possible pathophysiological roles of hyper-nitric oxaemia in cardiopulmonary bypass-related cardiovascular complications.


Assuntos
Ponte Cardiopulmonar/métodos , Óxido Nítrico/análise , Animais , Procedimentos Cirúrgicos Cardíacos/métodos , Modelos Animais de Doenças , Circulação Extracorpórea , Oxigenação por Membrana Extracorpórea , Óxido Nítrico/química , Óxido Nítrico/metabolismo , Oxigênio/metabolismo , Oxigenadores , Suínos , Tromboembolia/cirurgia
3.
J Nutr Health Aging ; 19(5): 548-54, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25923485

RESUMO

OBJECTIVES: To examine the effect of a dietary supplement containing bilberry extract (BE) on eye fatigue induced by acute video display terminal (VDT) loads. DESIGN AND SETTING: A prospective, randomized, double-blind, placebo-controlled study was performed from August 2012 to February 2013 in the Medical Corporation Jico-kai Yagi Hospital, and the Shinyokohama Shinoharaguchi Orthopedic Surgery and Dermatology Clinic, in Japan. PARTICIPANTS: Two hundred eighty-one office workers aged 20-40 years that used VDTs were screened by critical flicker fusion (CFF) and near point accommodation (NPA). INTERVENTION: The participants were randomized to either a BE (480 mg/day) or placebo (vehicle) group, and took allocated capsule, daily, for 8 weeks. MEASUREMENTS: The CFF, NPA, contrast visual acuity, functional visual acuity, keratoconjunctival epithelial damage, and fluorescein tear film break-up time were examined, and 18 subjective symptoms of eye fatigue were evaluated by questionnaire. Adverse events were reported via medical interviews. Data were collected both before and after VDT load at baseline, and 4, and 8 weeks after daily supplementation with either BE or placebo. RESULTS: Of 281 participants screened, 88 having relatively lower levels of CFF and NPA were enrolled in the study. Of these, 37 control and 43 BE group subjects completed the study. The VDT load-induced reduction in CFF was alleviated after 8 weeks of BE supplementation (95% confidence interval, 0.10-1.60; p=0.023), in contrast to placebo supplementation, while NPA variation was not. Of the subjective symptoms of eye fatigue, VDT load-induced ocular fatigue sensation, ocular pain, eye heaviness, uncomfortable sensation, and foreign body sensation were mitigated more in the BE group than in the control group, at week 8 (p<0.05). There were no severe adverse events in either group. CONCLUSIONS: BE supplementation improved some of the objective and subjective parameters of eye fatigue induced by VDT loads.


Assuntos
Astenopia/dietoterapia , Astenopia/prevenção & controle , Terminais de Computador , Suplementos Nutricionais , Extratos Vegetais/farmacologia , Vaccinium myrtillus/química , Acuidade Visual/efeitos dos fármacos , Acuidade Visual/fisiologia , Adulto , Astenopia/patologia , Astenopia/fisiopatologia , Túnica Conjuntiva/efeitos dos fármacos , Túnica Conjuntiva/patologia , Suplementos Nutricionais/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Japão , Masculino , Extratos Vegetais/efeitos adversos , Inquéritos e Questionários , Lágrimas , Adulto Jovem
4.
Mutat Res ; 63(1): 139-46, 1979 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-118373

RESUMO

The effectiveness of 14.1 MeV neutrons relative to 200 kV X-rays for the induction of the various kinds of dumpy mutation in mature sperm of Drosophila melanogaster was investigated. The estimated RBE values are: 0.52 for all complete mutations; 0.64 for the (olv, ov) types; 0.33 for the (ol, lv, o, v, c) types; 0.33 for all fractional mutations. These data lend support to the thesis that (1) complete dumpy mutations of the olv and ov types are more frequently associated with chromosomal aberrations than those of the ol, lv, o, v and c types, and (2) fractional mutations and complete mutations of the (ol, lv, o, v, c) types are most probably point mutational events.


Assuntos
Aberrações Cromossômicas , Cromossomos/efeitos da radiação , Drosophila melanogaster/genética , Mutação , Animais , Mapeamento Cromossômico , Relação Dose-Resposta à Radiação , Feminino , Masculino , Nêutrons , Fenótipo , Espermatozoides/efeitos da radiação , Raios X
5.
Mutat Res ; 122(3-4): 315-20, 1983 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-6419091

RESUMO

The mutagenicities of the products of pyrolysis of tryptophan, Trp-P-1 and Trp-P-2, on Drosophila melanogaster were examined by measuring the effects of these compounds in inducing recessive lethals and somatic eye-color mutations. Since negative results have already been obtained by the standard procedure in males, Trp-P-1 and Trp-P-2 (0.75 to 6 mg/ml) in sucrose solution were given to females for assay of recessive lethal mutations in X-chromosomes. These compounds caused a marginal increase above the control level in the mutation frequency. For the assay of effects on somatic eye-color mutations, Trp-P-1 (200 and 400 ppm) and Trp-P-2 (400 and 800 ppm) were fed to male larvae of a tester strain carrying a genetically unstable marker set of z and w+ on the X-chromosome. These compounds caused dose-dependent increases above the control level in somatic eye-color mutations in adults. It is concluded that, under the conditions used, the somatic eye-color mutation system was more sensitive than the recessive lethal system to the mutagenic effects of tryptophan pyrolysates.


Assuntos
Carbolinas/toxicidade , Genes Letais/efeitos dos fármacos , Genes Recessivos/efeitos dos fármacos , Indóis/toxicidade , Mutagênicos/toxicidade , Mutação , Cromossomos Sexuais/efeitos dos fármacos , Animais , Drosophila melanogaster/efeitos dos fármacos , Drosophila melanogaster/genética , Cor de Olho , Feminino , Frequência do Gene , Masculino , Testes de Mutagenicidade , Fatores Sexuais
6.
Carbohydr Res ; 251: 203-12, 1994 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-8149373

RESUMO

Erlose [beta-D-fructofuranosyl O-alpha-D-glucopyranosyl-(1-->4)-D-glucopyranoside] trihydrate, C18H32 O16.3H2O, M(r) = 558.48, is orthorhombic, P2(1)2(1)2(1) with a = 31.164(7), b = 13.111(5), c = 11.636(5) A, and Z = 8. The structure was solved by direct methods, and refined to R = 0.035 for 3926 observed reflections. The unit cell contains two independent molecules having a similar conformation. The conformation of the alpha-(1-->2) glycosidic linkage is similar to that observed in erlose monohydrate, whereas the conformation of the alpha-(1-->4) glycosidic linkage differs significantly. The molecule has no intramolecular hydrogen-bonds except for the minor components of three-center bonds, but indirect intramolecular hydrogen-bonds through the water molecules are formed. The hydrogen-bond system in the crystal structure consists of infinite and finite chains crosslinked by water molecules.


Assuntos
Cariostáticos/química , Edulcorantes/química , Trissacarídeos/química , Configuração de Carboidratos , Sequência de Carboidratos , Cristalografia por Raios X , Ligação de Hidrogênio , Modelos Químicos , Modelos Moleculares , Dados de Sequência Molecular , Água/química
7.
Carbohydr Res ; 240: 39-45, 1993 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-8458014

RESUMO

Erlose [O-beta-D-fructofuranosyl-(1-->2)-O-alpha-D-glucopyranosyl-(1-->4)- alpha-D-glucopyranoside] monohydrate, C18H32O16.H2O, M(r) = 522.45, is orthorhombic, P2(1)2(1)2(1) with a = 30.748 (3), b = 8.757 (1), c = 8.270 (1) A, and Z = 4. The structure was solved by direct methods, and refined to R = 0.048 for 1909 observed reflections. The torsion angles about the (1-->2) and (1-->4) glycosidic bonds are similar to those observed in other sucrose- and maltose-like oligosaccharides. The maltose moiety has an O-3'-H...O-2 intramolecular hydrogen-bond, but the sucrose moiety has no intramolecular hydrogen bonds. The hydrogen bonding in the crystal includes infinite and finite chains crosslinked by the water molecule.


Assuntos
Edulcorantes/química , Trissacarídeos/química , Configuração de Carboidratos , Sequência de Carboidratos , Ligação de Hidrogênio , Dados de Sequência Molecular , Difração de Raios X
8.
Carbohydr Res ; 241: 63-9, 1993 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-8472262

RESUMO

The crystal and molecular structure of beta-D-fructofuranosyl alpha-D-xylopyranoside (xylosucrose) hemihydrate, C11H20O10.0.5H2O, is orthorhombic, P2(1)2(1)2, with a = 20.919(5), b = 18.727(2), c = 7.071(1) A, V = 2770.1(2) A3, Z = 8, and Dx = 1.541 g.cm-3. The structure was solved by direct methods and refined to R = 0.040 for 2564 observed reflections. Two independent xylosucrose molecules exist in the unit cell, and their conformations about the 1-->2' glycosidic bond are similar to sucrose. The orientations of the primary hydroxyl groups in the two molecules differ. An O-1'...O-2 intramolecular hydrogen bond was observed in the one molecule, while an O-6'...O-5 intramolecular hydrogen bond was observed in the other involving disorder of O-6'.


Assuntos
Sacarose/análogos & derivados , Sequência de Carboidratos , Ligação de Hidrogênio , Modelos Moleculares , Dados de Sequência Molecular , Sacarose/química , Difração de Raios X
14.
Eur J Biochem ; 225(1): 369-74, 1994 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-7925458

RESUMO

We have determined the crystal structure of alpha-pokeweed antiviral protein, a member of ribosome-inactivating proteins, at 0.23 nm resolution, by the molecular-replacement method. The crystals belong to the space group P2(1)2(1)2 with unit-cell dimensions a = 4.71, b = 11.63 and c = 4.96 nm, and contain one protein molecule/asymmetric unit based on a crystal volume/unit protein molecular mass of 2.1 x 10(-3) nm3/Da. The crystallographic residual value was reduced to 17.2% (0.6-0.23 nm resolution) with root-mean-square deviations in bond lengths of 1.9 pm and bond angles of 2.2 degrees. The C alpha-C alpha distance map shows that alpha-pokeweed antiviral protein is composed of three modules, the N-terminal (Ala1-Leu76), the central (Tyr77-Lys185) and the C-terminal (Tyr186-Thr266) modules. The substrate-binding site is formed as a cleft between the central and C-terminal modules and all the active residues exist on the central module. The electrostatic potential around the substrate-binding site shows that the central and C-terminal module sides of this cleft have a negatively and a positively charged region, respectively. This charge distribution in the protein seems to provide a suitable interaction with the substrate rRNA.


Assuntos
Antivirais/química , N-Glicosil Hidrolases , Proteínas de Plantas/química , Estrutura Secundária de Proteína , Sequência de Aminoácidos , Sítios de Ligação , Clonagem Molecular , Cristalografia por Raios X/métodos , Modelos Moleculares , Dados de Sequência Molecular , Proteínas de Plantas/biossíntese , Proteínas de Plantas/metabolismo , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Proteínas Inativadoras de Ribossomos Tipo 1 , Homologia de Sequência de Aminoácidos
15.
Chem Pharm Bull (Tokyo) ; 45(10): 1631-41, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9353891

RESUMO

A series of renin inhibitors containing the (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol (2-amino-3,5-anti-diol) fragment as a novel transition-state mimic was synthesized, and their biological activities were evaluated. All of the synthesized compounds containing the 2-amino-3,5-anti-diol fragment at the P1-P1' position showed high in vitro renin-inhibitory activity with IC50 values in the 10(-8)-10(-10) M range, and most of them caused a reduction of blood pressure when administered orally to salt-depleted, conscious marmosets. The inhibitor (29) with the 4-hydroxypiperidine residue at the P4 position showed the highest activity in terms of both potency and duration of the blood pressure-lowering effect.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/síntese química , Anti-Hipertensivos/síntese química , Pressão Sanguínea/efeitos dos fármacos , Dipeptídeos/química , Álcoois Graxos/química , Renina/antagonistas & inibidores , Administração Oral , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Animais , Anti-Hipertensivos/farmacologia , Callithrix , Catepsina D/antagonistas & inibidores , Humanos , Espectroscopia de Ressonância Magnética , Pepsina A/antagonistas & inibidores , Renina/sangue , Sistema Renina-Angiotensina/efeitos dos fármacos , Cloreto de Sódio , Especificidade da Espécie , Espectrometria de Massas de Bombardeamento Rápido de Átomos , Relação Estrutura-Atividade
16.
Cell ; 90(6): 1085-95, 1997 Sep 19.
Artigo em Inglês | MEDLINE | ID: mdl-9323136

RESUMO

Hematopoietic prostaglandin (PG) D synthase is the key enzyme for production of the D and J series of prostanoids in the immune system and mast cells. We isolated a cDNA for the rat enzyme, crystallized the recombinant enzyme, and determined the three-dimensional structure of the enzyme complexed with glutathione at 2.3 A resolution. The enzyme is the first member of the sigma class glutathione S-transferase (GST) from vertebrates and possesses a prominent cleft as the active site, which is never seen among other members of the GST family. The unique 3-D architecture of the cleft leads to the putative substrate binding mode and its catalytic mechanism, responsible for the specific isomerization from PGH2 to PGD2.


Assuntos
Oxirredutases Intramoleculares , Isomerases/química , Isomerases/genética , Animais , Sítios de Ligação/fisiologia , Clonagem Molecular , Cristalografia , DNA Complementar , Epoprostenol/metabolismo , Regulação Enzimológica da Expressão Gênica , Hematopoese/fisiologia , Isomerases/metabolismo , Isomerismo , Lipocalinas , Dados de Sequência Molecular , Prostaglandina D2/química , Prostaglandina D2/metabolismo , Prostaglandina H2 , Prostaglandinas H/química , Prostaglandinas H/metabolismo , Estrutura Terciária de Proteína , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Homologia de Sequência de Aminoácidos , Especificidade por Substrato , Tromboxano A2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA